June 16, 2023 – INDICAID™ COVID-19 Rapid Antigen Test approved by Japan’s health ministry.
The INDICAID COVID-19 Antigen Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-coV-2 indirect anterior nasal swab specimens from individuals who are suspected of COVID-19.
For use with direct anterior nasal and nasopharyngeal swab specimens, non-invasive test procedures
Rapid results within 20 minutes
Detect SARS-CoV-2 nucleocapsid protein antigen
Effective in Detecting Omicron Variant (B.1.1.529) and specific variants of new coronavirus.*
Accuracy: Sensitivity 88.9%; Specificity 96.8%; Overall accuracy 95.6%
For additional information, https://bicmedical.com/product/antigen-test/